|
18F-FDG PET identified the average increase amyloid-beta plaques among individuals whose mothers had been diagnosed with Alzheimer’s disease compared to others with no family history of dementia, according to research findings published online March 15 in the Proceedings of the National Academy of Sciences.
FDG-PET and PET/CT may be valuable diagnostic tools for the evaluation of children with fever of unknown origin and unexplained signs of inflammation, according to a study published in the January issue of European Journal of Nuclear Medicine and Molecular Imaging.
Seven medical imaging societies have written a joint letter asking the Centers for Medicare and Medicaid Services (CMS) to provide coverage for two FDG PET scans for initial patient treatment evaluation, as opposed to the one scan CMS now covers.
Research presented at the 2009 European Association of Nuclear Medicine (EANM) conference in Barcelona, Spain, suggests that FDG PET is useful in monitoring response to antimycobacterial treatment in patients with pulmonary tuberculosis and can direct alternative therapy in case of resistant disease.
|
Pre-treatment maximal standardized uptake value (SUVmax) from FDG PET imaging of the primary tumor in head and neck squamous cell carcinoma patients is a strong predictor of prognosis, while pre-treatment SUVmax of the lymphadenopathy is significantly associated with distant metastasis, according to a study presented on Feb. 26 at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz.
FDG-PET brain imaging has shown that cocaine abusers may retain some ability to inhibit craving which may be therapeutically beneficial in addiction, according to research published online Nov. 18 in NeuroImage.
FDG PET and CT are equivalent in upstaging in patients with melanoma; however, FDG PET detected more metastatic sites, especially bone and subcutaneous, according to a study in the Oct. 1 issue of the Journal of Clinical Oncology.
Written by Sarah Lamberti
As personalized medicine attempts to revolutionize healthcare, giving patients access to tailored medical care, PET/CT is emerging with the promise of personalized therapies for oncology, including women’s cancers to provide the right patient with the right treatment at the right time.
|